Skip Navigation

Cardiovascular Research 2005 66(2):256-264; doi:10.1016/j.cardiores.2005.02.012
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kaye, D.
Right arrow Articles by Esler, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaye, D.
Right arrow Articles by Esler, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2005, European Society of Cardiology

Sympathetic neuronal regulation of the heart in aging and heart failure

David Kayea,* and Murray Eslerb

aWynn Department of Metabolic Cardiology, Baker Heart Research Institute, PO Box 6492 St. Kilda Road Central, Melbourne, Vic 8008, Australia
bDivision of Cardiovascular Neuroscience, Baker Heart Research Institute, Melbourne, Australia

* Corresponding author. Tel.: +61 3 9276 3265; fax: +61 3 9276 1044. Email address: david.kaye{at}baker.edu.au

The documentation of preferential activation of the cardiac sympathetic outflow in patients with heart failure swept aside an entrenched notion that there was a functional sympathetic denervation of the failing heart and provided a theoretical basis for the clinical evaluation of β-adrenergic blocker therapy in this condition. The demonstration that heightened sympathetic nervous system activity is central to the pathogenesis and progression of congestive heart failure (CHF) has now led to the rational use of β-adrenoceptor blockade in CHF. More recently, it has also emerged that the aging heart exhibits some of the characteristic changes in autonomic control which are seen in CHF. Accordingly, alterations in cardiac sympathetic nerve function are now thought to contribute also to the pathophysiology of the aging heart. Furthermore, there is evidence that in humans, sympathoexcitatory rostral projections of brainstem noradrenergic neurons to the forebrain are important in the sympathetic nervous activation of both heart failure and aging. Given these similarities, in this review we compare and contrast the neurobiology of the sympathetic nervous system in the failing heart and the healthy, aging heart, and consider whether the sympathetic activation accompanying aging may, perhaps, underlie and contribute to the neural pathophysiology of heart failure. Our conclusion is, on balance, that this proposition is not supported by the available evidence.

KEYWORDS Norepinephrine; Epinephrine; Mental stress; Norepinephrine transporter; Nerve growth factor; Adrenoceptors


Time for primary review 15 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
PhysiologyHome page
M. Kang, K. Y. Chung, and J. W. Walker
G-Protein Coupled Receptor Signaling in Myocardium: Not for the Faint of Heart
Physiology, June 1, 2007; 22(3): 174 - 184.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Pepe and E. G. Lakatta
Aging hearts and vessels: Masters of adaptation and survival
Cardiovasc Res, May 1, 2005; 66(2): 190 - 193.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.